Ototoxicity: Mechanisms of Cochlear Impairment and its Prevention

Current Medicinal Chemistry

Volumn 18, Issue 31, 2011, Pages 4866-4871

  Tabuchi, K ^a   Nishimura, B ^a   Nakamagoe, M ^a   Hayashi, K ^a   Nakayama, M ^a   Hara, A ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aminoglycosides; Cisplatin; Non steroidal anti inflammatory drugs (NSAIDs); Ototoxicity

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIFOSTINE; AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CEP 1347; CISPLATIN; DIBEKACIN; DIHYDROSTREPTOMYCIN; ESTRADIOL; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GENTAMICIN; GINKGO BILOBA EXTRACT; ISEPAMICIN; KANAMYCIN; MANNITOL; METHIONINE; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEOMYCIN; NETILMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; STREPTOMYCIN; STRESS ACTIVATED PROTEIN KINASE; THIOCTIC ACID; TOBRAMYCIN; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CARDIOTOXICITY; COCHLEA PROSTHESIS; DRUG HYPERSENSITIVITY; GASTROINTESTINAL TOXICITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAIR CELL; HEAD AND NECK CANCER; HEARING LOSS; HUMAN; KIDNEY DISEASE; LIPID PEROXIDATION; LUNG CANCER; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; OVARY CANCER; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TESTIS CANCER; TINNITUS;

AMINOGLYCOSIDES; ANTI-INFLAMMATORY AGENTS; CISPLATIN; COCHLEA; HEARING LOSS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES;

EID: 80054863077     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797535254     Document Type: Article

References (109)

1. Rybak, .LP.; Ramkumar, V. Ototoxicity. Kindey Int., 2007, 72, 931-935.
2. Santucci, R.A.; Krieger, J.N. Gentamicin for the practicing urologist: Review of efficacy, single dailydosing and "switch" therapy. J. Urol., 2000, 163, 1076-1084. (Pubitemid 30169366)
3. Guthrie, O.W. Aminoglycoside induced ototoxicity. Toxicology, 2008, 249, 91-96.
4. Moore, R.D.; Smith, C.R.; Lietman, P.S. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J. Infect. Dis., 1984, 149, 23-30. (Pubitemid 14179885)
5. Lerner, S.A.; Schmitt, B.A.; Seligsohn, R.; Matz, G.J. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am. J. Med., 1986, 80, 98-104. (Pubitemid 16036773)
6. Brouet, G.; Marche, J.; Chevallier, J.; Liot, F.; Le Meur, G.; Bergogne. Experimental and clinical studies on kanamycin in tuberculous infection. Rev. Tuberc. Pneumol. (Paris), 1959, 23, 949-988.
7. Waguespack, J.R.; Ricci, A.J. Aminoglycoside ototoxicity: Permeant drugs cause permanent hair cell loss. J. Physiol., 2005, 567, 505-521.
8. Priuska, E.; Schacht, J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem. Pharmacol., 1995, 50, 1749-1752. (Pubitemid 26011387)
9. Clerici, W.J.; Hensley, K.; DiMartino, D.L.; Buttrfield, D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res., 1996, 98, 116-124. (Pubitemid 26306760)
10. Hirose, K.; Hockenbery, D.M.; Rubel, E.W. Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear. Res., 1997, 104, 1-14. (Pubitemid 27092045)
11. Sha, S.H.; Schacht, J. Stimulation of free radical formation by aminoglycoside antibiotics. Hear. Res., 1999, 128, 112-118. (Pubitemid 29083253)
12. Canlon, B.J.; Smith, D.W. Supplemental iron exacerbates animoglycoside ototoxicity in vitro. Hear. Res., 1998, 115, 1-5. (Pubitemid 28062818)
13. Sha, S.H.; Zajic, G.; Epstein, C.J.; Schacht, J. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol. Neurootl., 2001, 6, 117-123. (Pubitemid 32710231)
14. Takumida, M.; Anniko, M. Nitric oxide in guinea pig vestibular sensory cells following gentamicin exposure in vitro. Acta Otolaryngol., 2001, 121, 346-350. (Pubitemid 32472988)
15. Van De Water, T.R.; Lallemend, F.; Eshraghi, A.A.; Ahsan, S.; He, J.; Guzman, J.; Polak, M.; Malgrange, B.; Lefebvre, P.P.; Staecker, H.; Balkany, T.J. Caspases, the enemy within, and their role in oxidative stress-induced apoptosis of inner ear sensory cells. Otol. Neurootol., 2004, 25, 627-632. (Pubitemid 39079792)
16. Bodmer, D.; Brors, D.; Pak, K.; Bodmer, M.; Ryan, A.F. Gentamicininduced hair cell death is not dependent on the apoptosis receptor Fas. Laryngoscope, 2003, 113, 452-455. (Pubitemid 36297023)
17. Cunningham, L.L.; Cherg, A.G.; Rubel, E.W. Caspase activation in hair cells of the mouse utricle exposed to neomycin. J. Neurosci., 2002, 22, 8532-8540. (Pubitemid 35387593)
18. Dehne, N.; Rauen, U.; de Groot, H.; Lautermann, J. Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear. Res., 2002, 169, 47-55. (Pubitemid 34733018)
19. Tabuchi, K.; Pak, K.; Chavez, E.; Ryan, A.F. Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience, 2007, 149, 213-222. (Pubitemid 47488647)
20. Kim, E.K.; Choi, E-J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta, 2009, 1802, 396-405.
21. Ylikoski, J.; Xing-Qun, L.; Virkkala, J.; Pirvola, U. Blockade of c-Jun Nterminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear. Res., 2002, 166, 33-43. (Pubitemid 34626457)
22. Wang, J. Llovd Faulconbridge, R.V.; Fetoni, A.; Guitton, M.J.; Pujol, R.; Puel, J.L. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology, 2003, 45, 380-393. (Pubitemid 36836134)
23. Nakamagoe, M.; Tabuchi, K.; Uemaetomari, I.; Nishimura, B.; Hara, A. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Hear. Res., 2010, 261, 67-74.
24. Wei, X.; Zhao, L.; Liu, J.; Dodel, R.C.; Farlow, M.R.; Du, Y. Minocycline prevents gentamicin-induced ototxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience, 2005, 131, 513-521. (Pubitemid 40222458)
25. Sha, S.H.; Chen, F.Q.; Schacht, J. Activation of cell death pathways in the inner ear of the aging CBA/J mouse. Hear. Res., 2009, 254, 92-99.
26. Tabuchi, K.; Oikawa, K.; Hoshino, T.; Nishimura, B.; Hayashi, K.; Yanagawa, T.; Warabi, E.; Ishii, T.; Tanaka, S.; Hara, A. Cochlear protection from acoustic injury by inhibitors of p38 mitogen-activated protein kinase and sequestosome 1 stress protein. Neuroscience, 2010, 166, 665-670.
27. Tabuchi, K.; Nishimura, B.; Tanaka, S.; Hayashi, K.; Hirose, Y.; Hara, A. Ischemia-reperfusion injury of the cochlea: Pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species. Curr. Neuropharmacol., 2010, 8, 128-134.
28. Murashita, H.; Tabuchi, K.; Hara, A. Ototoxicity: C ause of hair cell death. In Recent advances in auditory neuroscience. Eds. Tabuchi K, Hara A. Research signpost. Kerala. 2007. Pp. 19-26.
29. Fetoni, A.R.; Sergi, B.; Scarano, E.; Paludetti, G.; Ferraresi, A.; Troiani, D. Protective effects of alpha-tocopherol against gentamicin-induced Otovestibulo toxicity: A n experimental study. Acta Otolaryngol., 2003, 123, 192-197. (Pubitemid 36359790)
30. Sha, S.H.; Schacht, J. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear. Res., 2000, 142, 34-40. (Pubitemid 30169125)
31. Canlon, B.J.; Aran, J.M.; Erre, J.P.; Smith, D.W. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear. Res., 1999, 128, 40-44. (Pubitemid 29083243)
32. Song, B.B.; Sha, S.H.; Schacht, J. Iron chlators protects from aminoglycoside-induced cochleo- and vestibule-toxicity. Free Radic. Biol. Med., 1998, 25, 189-195.
33. Yang, T.H.; Young, Y.H.; Liu, S.H. EGb 761 (Ginkgo biloba) protects cochlear hair cells against hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. J. Nutr. Biochem., 2010, Epub ahead of print.
34. McFadden,S.L.; Ding, D.; Salvemini, D.; Salvi, R.J. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Txicol. Appl. Pharmacol., 2003, 186, 46-54. (Pubitemid 36262948)
35. Song, B.B.; Schacht, J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in viro. Hear. Res., 1996, 94, 87-93. (Pubitemid 26001109)
36. Sha, S.H.; Schacht, J. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest., 1999, 79, 807-813. (Pubitemid 29344492)
37. Schimmer, A.D. Inhibitor of apoptosis protein: Translating basic knowledge into clinical practice. Cancer Res., 2004, 64, 7183-7190. (Pubitemid 39372048)
38. Corbacella, E.; Lanzoni, I.; Ding, D.; Previati, M.; Salvi, R. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear. Res., 2004, 197, 11-18. (Pubitemid 39410688)
39. Maceyka, M.; Payne, S.G.; Milstien, S.; Spiegel, S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta, 2002, 1585, 193-201. (Pubitemid 36096858)
40. Nishimura, B.; Tabuchi, K.; Nakamagoe, M.; Hara, A. The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. Neurosci. Lett., 2010, 485, 1-5.
41. Himeno, C.; Komeda, M.; Izumikawa, M.; Takemura, K.; Yagi, M.; Weiping, Y.; Doi, T.; Kuriyama, H.; Miller, J.M.; Yamashita, T. Intracochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear. Res., 2002, 167, 61-70. (Pubitemid 34756851)
42. Tabuchi, K.; Nakamagoe, M.; Nishimura, B.; Hayashi, K.; Nakayama, M.; Hara, A. Protective effects of corticosteroids and neurosteroids on cochlear injury. Med. Chem., 2011, 7, 140-144.
43. Leitner, M.G.; Halaszovich, C.R.; Oliver, D. Aminoglycoside inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4, 5)bisphosphate. Mol. Pharmacol., 2011, 79, 51-60.
44. Kawamoto, K.; Yagi, M.; Stover, T.; Kanzaki, S.; Raphael, Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol. Ther., 2003, 7, 484-492. (Pubitemid 36553417)
45. Zhao, H.; Li, R.; Wang, Q.; Deng, J.H.; Han, D.; Bai, Y.; Young, W.Y.; Guan, M.X. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am. J. Human Genet., 2004, 74, 139-152. (Pubitemid 38085245)
46. Rydzanicz, M.; Wrobel, M.; Pollak, A.; Gawecki, W.; Brauze, D.; Kostrzewska-Poczekaj, M.; Wojsyk-Banaszak, I.; Lechowicz, U.; Mueller- Malesinska, M.; Oldak, M.; Pioski, R.; Skarzynski, H.; Szyfter, K. Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with nonsyndromic and aminoglycoside-induced hearing loss. Biochem. Biophys. Res. Commun., 2010, 395, 116-121.
47. Moazed, D.; Noller, H. Transfer-RNA shields specific nucleotides in 16s ribosomal-RNA from attack by chemical probes. Cell, 1986, 35, 433-436.
48. Prezant, T.; Agapian, J.; Bohlman, M.; Bu, S.; Oztas, S.; Qiu, W.; Arnos, K.; Cortopassi, G.; Jaber, L.; Rotter, J.; Shohat, M.; Fischelghodsian, N. Mitochondrial ribosomal-RNA mutation associated with both antibioticinduced and non-syndromic deafness. Nat. Genet., 1993, 4, 289-294. (Pubitemid 23205179)
49. Hobbie, S.; Bruell, C.; Akshay, S.; Kalapala, S.; Shcherbakov, D.; Bottger, E. Mitochondrial deafness alleles confer misreading of the genetic code. Proc. Natl. Acad. Sci. USA., 2008, 105, 3244-3249. (Pubitemid 351723538)
50. Cardinaal, R.M.; de Groot, J.C.; Huizing, E.H.; Veldman, J.E.; Smoorenburg, G.F. Cisplatin-induced ototoxicity: Morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs? Hear. Res., 2000, 144,147-156. (Pubitemid 30301683)
51. Van Ruijven, M.W.; de Groot ,J.C.; Klis, S.F.; Smoorenburg, G.F. The cochlear targets of cisplatin: A n electrophysiological and morphological timesequence study. Hear. Res., 2005, 205, 241-248. (Pubitemid 40813286)
52. Meech, R.P.; Cambell, K.C.; Hughes, L.F.; Rybak, L.P. A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear. Res., 1998, 124, 44-59. (Pubitemid 28483064)
53. De Jongh, F.E.; van Veen, R.N.; Veltman, S.J.; de Wit, R.; van der Burg, M.E.; van den Bent, M.J.; Plating, A.S.; Gravelad, W.J.; Stoter, G. Weekly high-dose cisplatin is a feasible treatment option: A nalysis on prognostic factors for toxicity in 400 patients. Br. J. Cancer, 2003, 88, 1199-1206. (Pubitemid 36606333)
54. Li, Y.; womer, R.B.; Silber, J.H. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur. J. Cancer, 2004, 40, 2445-2451. (Pubitemid 39424959)
55. Knight. K.R.G.; Kraemer, D.F.; Neuwelt, E.A. Ototoxicity in children receiving platinum chemotherapy: Understanding a commonly occurring toxicity that may influence academic and social development. J. Clin. Oncol., 2005, 23, 8588-8896.
56. Chen, W.C.; Jackson, A.; Budnick, A.S.; Pfister Din, G.; Kraus, D.H.; Hunt, M.A.; Stambuk, H.; Levegrum, S.; Wolden, S.L. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer, 2006, 106, 820-829. (Pubitemid 43238449)
57. Rybak, L.P.; Husain, K.; Morris, C.; Whitworth, C.; Somani, S. Effect of protective agents against cisplatin ototoxicity. Am. J. Otol., 2000, 149, 189-198.
58. Kelly, T.C.; Whitworth, C.A.; Husain, K.; Rybak, L.P. Aminoguanidine reduces cisplatin ototoxicity. Hear. Res., 2003, 186, 10-16. (Pubitemid 37476445)
59. Watanabe, K.; Hess, A.; Michel, O.; Yagi, T. Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs. Anticancer Drugs, 2000, 11, 731-735.
60. Kim, H.J.; Lee, J.H.; Kim, S.J.; Oh, G.S.; Moon, H.D.; Kwon, K.B.; Park, C.; Park, B.H.; Lee, H.K.; Chung, S.Y.; Park, R.; So, H.S. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J. Neurosci., 2010, 30, 3933-3946.
61. DeWoskin, R.S.; Riviere, J.E. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by a single dose of diethylhiocarbamate but not mesna. Toxicol. Appl. Pharmacol., 1992, 112, 182-189.
62. Pigeolet, E.; Corbisier, P.; Houbion, A.; Lambert, D.; Michiels, C.; Raes, M.; Zachary, M.D.; Ramacle, J. Glutathione peroxidase, superoxide dismutase and catalase inactivation by proxides and oxygen derived free radicals. Mech. Aging Dev., 1990, 51, 283-297. (Pubitemid 20041562)
63. Somani, S.M.; Husain, K.; Jagannathan, R.; Rybak, L.P. Amelioration of cisplatin-induced oto- and nephrotoxicity by protective agents. Ann. Neurosci., 2001, 8, 101-113.
64. Wang, J.; Ladrech, S.; Pujol, R.; Brabet, P.; Van De Water, T.R.; Puel, J.L. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res., 2004, 64, 9217-9224. (Pubitemid 39665538)
65. Church, M.W.; Blakley, B.W.; Burqio, D.L.; Gupta, A.K. WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: D ose-dependent effects. J. Assoc. Res. Otolaryngol., 2004, 5, 227-237. (Pubitemid 39332094)
66. Feghali, J.G.; Liu, W.; Van De Water, T.R. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope, 2001, 111, 1147-1155. (Pubitemid 32625400)
67. Li, G.; Sha, S.H.; Zotova, E.; Arezzo, J.; Van De Water, T.; Shacht, J. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab. Invest., 2002, 82, 585-596. (Pubitemid 34522371)
68. Teranishi, M.; Nakashima, T.; Wakabayashi, T. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hear. Res., 2001, 151, 61-70.
69. Campbell, K.C.; Meech, R.P.; Rybak, L.P.; Hughes, L.F. The effect of Dmethionine on cochlear oxidative state with and without cisplatin administration: Mechanisms of otoprotection. J. Am. Acad. Audiol., 2003, 14, 144-156.
70. Whitworth, C.A.; Ramkumar, V.; Jones, B.; Tsukasaki, N.; Rybak, L.P. Protection against cisplatin ototoxicity by adenosine agonists. Biochem. Pharmacol., 2004, 67, 1801-1807. (Pubitemid 38479858)
71. Cooper, L.B.; Chan, D.K.; Roediger, F.C.; Shaffer, B.R.; Fraser, J.F.; Musatov, S.; Slesnick, S.H.; Kaplitt, M.G. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol. Neruotol., 2006, 27, 484-490.
72. Daldal, A.; Odabasi, O.; Serbetcioglu, B. The protective effect of intratympnic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol. Head Neck Surg., 2007, 137, 747-752. (Pubitemid 47632918)
73. Hill, G.W.; Morest, D.K.; Parham, K. Cisplatin-induced ototoxicity: E ffect of intratympanic dexamethasone injections. Otol. Neurotol., 2008, 29, 1005-1011.
74. So, H.S.; Kim, H.J.; Lee, J.H.; Park, S.Y.; Park, C.; Kim, Y.H.; Kim, J.K.; Lee, K.M,; Kim, K.S.; Chung, S.Y.; Jang, W.C.; Moon, S.K.; Chung, H.T.; Park, R.K. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell Death Differ., 2006, 13, 1763-1775. (Pubitemid 44390863)
75. More, S.S.; Akil, O.; Ianculesch, A.G.; Geier, E.G.; Lustig, L.R.; Giacomini, K.M. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J. Neurosci., 2010, 30, 9500-9509.
76. Chen, X.; Frisina, R.D.; Bowers, W.J.; Frisina, D.R.; Federoff, H.J., HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol. Ther., 2001, 3, 958-963. (Pubitemid 32611305)
77. Meen, E.; Blakley, B.; Quddusi, T. Brain-derived nerve growth factor in the treatment of sensorineural hearing loss. Laryngoscope, 2009, 119, 1590-1593.
78. Hoshino, T.; Tabuchi, K.; Hara, A. Effects of NSAIDs on the inner ear: Possible involvement in cochlear protection. Pharmaceuticals, 2010, 3, 1286-1295.
79. Cazals, Y. Auditory sensori-neural alterations induced by salicylate. Prog. Neurobiol., 2000, 62, 583-631. (Pubitemid 30407137)
80. Chyka, P.A.; Erdman, A.R.; Christianson, G.; Wax, P.M.; Booze, L.L.; Manoguerra, A.S.; Caravati, E.M.; Nelson, L.S.; Olson, K.R.; Cobaugh, D.J.; Scharman, E.J.; Woolf, A.D.; Troutman, W.G. Salicylate poisoning: A n evidence-based consensus guideline for out-of-hospital management. Clin. Toxicol., 2007, 45, 95-131.
81. Kujawa, S.G.; Fallon, M.; Bobbin, R.P. Intracochlear salicylate reduces lowintensity acoustic and cochlear microphonic distortion products. Hear. Res., 1992, 64, 73-80. (Pubitemid 23026527)
82. Ueda, H.; Yamamoto, Y.; Yanagita, N. Effect of aspirin on transiently evoked otoacoustic emissions in guinea pigs. ORL. J. Otorhinolaryngol. Relat. Spec., 1996, 58, 61-67. (Pubitemid 26151040)
83. Kakehat, S.; Santos-Sacchi, J. Effects of salicylate and lanthanides on outer hair cell motility and associated gating charge. J. Neurosci., 1996, 16, 4881-4889. (Pubitemid 26269650)
84. Tabuchi, K.; Tsuji, S.; Hara, A.; Kusakari, J. Effect of calmodulin antagonists on the compound action potential of the cochlea. Hear. Res., 2000, 145, 59-64. (Pubitemid 30365267)
85. Mammano, F.; Ashmore, J.F. Reverse transduction measured in the isolated cochlea by laser Michelson interferometry. Nature, 1993, 365, 838-841. (Pubitemid 23341025)
86. Puel, J.L.; Bobbin, R.P.; Fallon, M. Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol. Head Neck Surg., 1990, 102, 66-73 (Pubitemid 20038515)
87. Didier, A.; Miller, J.M.; Nuttall, A.L. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear. Res., 1993, 69, 199-206. (Pubitemid 23279610)
88. Dieler, R.; Shehata-Dieler, W.E.; Richter, C.P.; Klinke, R. Effects of endolymphatic and perilymphatic application of salicylate in the pigeon. ć: Fine structure of auditory hair cells. Hear. Res., 1994, 74, 85-98.ćć
89. Douek, E.E.; Dodson, H.C.; Bannister, L.H. The effects of sodium salicylate on the cochlea of guinea pigs. J. Laryngol. Otol., 1983, 97, 793-799. (Pubitemid 13041935)
90. Janssen, T.; Boege, P.; Oestreicher, E.; Arnold, W. Tinnitus and 2f1-f2 distortion product otoacoustic emissions following salicylate overdose. J. Acoust. Soc. Am., 2000, 107, 1790-1792. (Pubitemid 30141723)
91. Wu, T.; Lv, P.; Kim, H.J.; Yamoah, E.N.; Nuttall, A.L. Effect of salicylate on KCNQ4 of the guinea pig outer hair cell. J. Neurophysiol., 2010, 103, 1969-1977.
92. Wei, L.; Ding, D.; Salvi, R. Salicylate-induced degeneration of cochlea spiral ganglion neurons-apoptosis signaling. Neuroscience, 2010, 168, 288-299.
93. Chen, G.D.; Kermany, M.H.; D'Elia, A.; Ralli, M.; Tanaka, C.; Bielefeld, E.C.; Ding, D.; Henderson, D.; Salvi, R. Too much of a good thing: Longterm treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear. Res., 2010, 265, 63-69.
94. Miller, B.; Sarantis, M.; Traynelis, S.F.; Attwell, D. Potentiation fo NMDA receptor currents by arachidonic acid. Nature, 1992, 355, 722-725.
95. Ruel, J.; Chen, C.; Pujol, R.; Bobbin, R.P.; Puel, J.L. AMPA-preferring glutamate receptors in cochlear physiology of adult guinea pig. J. Physiol., 1999, 518, 667-680. (Pubitemid 29387238)
96. Ruel, J.; Bobbin, R.P.; Vidal, D.; Pujol, R.; Puel, J.L. The selective AMPA receptor antagonist GYKI 53784 blocks action potential generation and excitotoxicity in the guinea pig cochlea. Neuropharmacology, 2000, 39, 1959-1973. (Pubitemid 30645620)
97. Guitton, M.J.; Caston, J.; Ruel, J.; Johnson, R.M.; Pujol, R.; Puel, J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci., 2003, 23, 3944-3952. (Pubitemid 36958500)
98. Wei, L.; Ding, D.; Sun, W.; Xu-Friedman, M.A.; Salvi, R. Effects of sodium salicylate on spontaneous and evoked spike rate in the dorsal cochlear nucleus. Hear. Res., 2010, 267, 54-60.
99. Knipper, M.; Zimmermann, U.; Muller, M. Molecular aspects of tinnitus. Hear. Res., 2009, 266, 60-69.
100. Sun, W.; Lu, J.; Stolzberg, D.; Gray, L.; Deng, A.; Lobarinas, E.; Salvi, R.J. Salicylate increases the gain of the central auditory system. Neuroscience, 2009, 159, 325-334.
101. Norena, A.J.; Moffat, G.; Blanc, J.L.; Pezard, L.; Cazals, Y. Neural changes in the auditory cortex of awake guinea pigs after two tinnitus inducers: Salicylate and acoustic trauma. Neuroscience, 2010, 166, 1194-1209.
102. Hwang, J.H.; Chen, J.C.; Yang, S.Y.; Wang, M.F.; Liu, T.C.; Chan, Y.C. Expression of COX-2 and NMDA receptor genes at the cochlea and midbrain in salicylate-induced tinnitus. Layngoscope, 2011, 121, 361-364.
103. Eggermont, J.J. Role of auditory cortex in noise- and drug-induced tinnitus. Am. J. Audiol., 2008, 17, S162-S169.
104. Lamm, K.; Arnold, W. The effect of prednisolone and non-steroidal antiinflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear. Res., 1998, 115, 149-161. (Pubitemid 28062832)
105. Kopke, R.D.; Weisskopf, P.A.; Boone, J.L.; Jackson, R.L.; Wester, D.C.; Hoffer, M.E.; Lambert, D.C.; Charon, C.C.; Ding, D.L.; McBride, D. Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla. Hear. Res., 2000. 149. 138-146.
106. Yamashita, D.; Jiang, H.Y.; Le Prell, C.G.; Schacht, J.; Miller, J.M. Postexposure treatment attenuates noise-induced hearing loss. Neuroscience, 2005, 134, 633-642. (Pubitemid 41111790)
107. Hoshino, T.; Tabuchi, K.; Hirose, Y.; Uemaetomari, I.; Murashita, H.; Tobita, T.; Hara, A. The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury. Tohoku J. Exp. Med., 2008, 216, 53-59.
108. Coleman, J.; Huang, X.; Liu, J.; Kopke, R.; Jackson, R. Dosing study on the effectiveness of salicylate/N-acetylcysteine for prevention of noise-induced hearing loss. Noise Health, 2010, 12, 159-165.
109. Hyppolito, M.A.; de Oliveira, J.A.; Rossato, M. Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur. Arch. Otorhinolaryngol., 2006, 263, 798-803. (Pubitemid 44127303)